Excellent tony...hopefully IPCI's already received FDA approval on FocalinXR prior to Roth's annual growth play conference in march which if they do...would for sure bring in some MASSIVE street buying to say the least>>>
From IPCI web site last sentence .here is the LINK we expect that our generic version of Focalin XR will be launched in the fourth quarter of 2012. We have a ten year profit-sharing agreement with Par from commercial launch of the product.